177 related articles for article (PubMed ID: 22129193)
1. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
Vasudev P; Onuma K
Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
[TBL] [Abstract][Full Text] [Related]
2. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
4. A case of estrogen receptor positive secretory carcinoma in a 9-Year-old girl with ETV6-NTRK3 fusion gene.
Yorozuya K; Takahashi E; Kousaka J; Mouri Y; Yoshida M; Fujii K; Akizuki M; Nakano S; Fukutomi T; Umemoto Y; Yokoi T; Imai H
Jpn J Clin Oncol; 2012 Mar; 42(3):208-11. PubMed ID: 22210920
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
6. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
8. ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.
Grabellus F; Worm K; Willruth A; Schmitz KJ; Otterbach F; Baba HA; Kimmig R; Metz KA
Breast; 2005 Feb; 14(1):71-4. PubMed ID: 15695086
[TBL] [Abstract][Full Text] [Related]
9. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
[TBL] [Abstract][Full Text] [Related]
10. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
11. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
12. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH
Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
[TBL] [Abstract][Full Text] [Related]
13. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
14. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
15. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
18. Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma.
Huo L; Bell D; Qiu H; Sahin A; Wu Y; Sneige N
Ann Diagn Pathol; 2011 Apr; 15(2):84-92. PubMed ID: 21163678
[TBL] [Abstract][Full Text] [Related]
19. [Triple-negative breast carcinoma--rewiev of current literature].
Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
[TBL] [Abstract][Full Text] [Related]
20. The prognostic importance of triple negative breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gülben K
Breast; 2008 Aug; 17(4):341-6. PubMed ID: 18450442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]